Sign in

CIK 0001855175

  • Non-accelerated filer
  • Smaller reporting company
  • Emerging growth company

Contineum Therapeutics, Inc.

Sign in to watch
Ticker
CTNM
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
271467257
Phone
+1 858-333-5280
Business address
3565 GENERAL ATOMICS COURT, SUITE 200, SAN DIEGO, CA, 92121
  1. 4 Planned sale Chief Scientific Officer sold 8,124 shares at an average $16.02 ($130,164)
  2. 4 Planned sale Chief Scientific Officer sold 100 shares at $16.00 ($1,600)
  3. 4 Planned sale CEO and President sold 400 shares at $16.00 ($6,400)
  4. 4 Planned sale Chief Scientific Officer sold 400 shares at $16.00 ($6,400)
  5. 4 Planned sale Chief Scientific Officer sold 4,170 shares at an average $14.94 ($62,305)
  6. 4 Derivatives Options or other derivatives
  7. 4 Derivatives Options or other derivatives
  8. 4 Derivatives Options or other derivatives
  9. 4 Derivatives Options or other derivatives
  10. 4 Planned sale CMO & Head of Development sold 3,611 shares at an average $14.18 ($51,188)
  11. 4 Planned sale Chief Scientific Officer sold 4,170 shares at an average $10.44 ($43,543)
  12. 4 Planned sale CMO & Head of Development sold 3,611 shares at $12.06 ($43,558)
  13. 4 Planned sale Chief Scientific Officer sold 4,170 shares at $12.23 ($51,009)
  14. 4 Derivatives Options or other derivatives
  15. 4 Derivatives Options or other derivatives
  16. 4 Derivatives Options or other derivatives
  17. 4 Derivatives Options or other derivatives
  18. 4 Derivatives Options or other derivatives
  19. 4 Derivatives Options or other derivatives
  20. 4 Derivatives Options or other derivatives

Page 2 of 4 · 78 filings